The global 3D bioprinted human tissue market size was valued at USD 2.3 billion in 2024, driven by growing investments in biotechnology research and development across the globe. The market is expected to grow at a CAGR of 8.4% during the forecast period of 2025-2034, with the values likely to rise from USD 2.5 billion in 2025 to USD 4.8 billion by 2034. This remarkable growth is primarily...

"Executive Summary Pingueculum Drugs Market : CAGR Value :  Data Bridge Market Research analyses that the global pingueculum drugs market will grow at a CAGR of 7.3% during the forecast period of 2022 to 2029.   All statistical and numerical data is interpreted with the use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis. Few of the...

The advancement of trispecific antibodies is opening new doors in the field of cancer treatment. Unlike traditional monoclonal or bispecific antibodies, these novel agents are capable of engaging three distinct targets, which enhances immune cell activation and tumor cell recognition. As a result, trispecifics offer the potential for greater therapeutic precision and improved clinical...

Inside every cell, complex communication networks are constantly at work. These systems—known as signaling pathways—allow cells to respond to changes in their environment, control growth, defend against threats, and carry out essential biological tasks. One of the key methods cells use to transmit signals is phosphorylation, a process where a phosphate group is added to a protein to...

  The AACR Annual Meeting 2025 is a globally recognized event that brings together leading experts, researchers, and healthcare professionals to share groundbreaking discoveries in cancer research. As one of the most anticipated conferences in oncology, it provides a platform for unveiling the latest advancements in cancer treatments, diagnostics, and cutting-edge therapies. Attendees will...

    In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. Among the most promising strategies in this domain is the development of radioactive drug conjugates(RDCs). These innovative therapeutic agents combine the targeting capabilities of antibodies with the cytotoxic effects of radioactive isotopes, providing a...

    Traumatic Brain Injury (TBI) remains a pressing global health concern, affecting individuals across all age groups. The Traumatic Brain Injury Market: Insights, Trends, and Future Outlook by DelveInsight delves into current therapeutic strategies, emerging drug developments, and the future of TBI treatment. With increasing research, investment, and awareness, the TBI market is...

Artificial intelligence (AI) is transforming the biopharma industry by accelerating drug discovery, optimizing clinical trials, and enhancing patient outcomes. As AI technologies evolve, their integration into biopharma operations is breaking long-standing barriers, yet it also presents new challenges that require careful navigation. Understanding the dynamic relationship between AI and the...

Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research.   Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. This initiative represents a critical advancement in pursuing effective bladder...

    Alfa Cytology unveils advanced cancer immunotherapy development services.   Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. This initiative signifies a major leap forward in the development of more effective cancer therapies, aiming to boost both precision and...